Cargando…

Follow-up of asthma control and quality of life after discontinuation of omalizumab in severe asthmatic patients

Detalles Bibliográficos
Autores principales:	Nayci, Sibel, Ozgur, Eylem, Ozge, Cengiz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406114/ http://dx.doi.org/10.1186/1939-4551-8-S1-A75

Ejemplares similares

Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
por: O’Quinn, John, et al.
Publicado: (2014)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
por: Villela, Rosangela, et al.
Publicado: (2015)

A case report of ABPA, cystic fibrosis and asthma treated with omalizumab
por: Mazza, JA, et al.
Publicado: (2015)

Exhaled nitric oxide and quality of life in asthmatic teenagers
por: Carvalho, Rosa Maria, et al.
Publicado: (2015)

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
por: Cameron, Jodi, et al.
Publicado: (2014)

Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
por: Sintobin, Ina, et al.
Publicado: (2015)

Asthma treatment adherence among asthmatic patients in Yazd
por: Rahimi, Azam, et al.
Publicado: (2012)

Correlation between asthma control and quality of life in patients with moderate and severe asthma
por: Valory, Mary Jane Lisboa, et al.
Publicado: (2015)

Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma
por: Jung, Jae-Woo, et al.
Publicado: (2021)

Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma
por: Jung, Jae-Woo, et al.
Publicado: (2021)

Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
por: Barrios, Jonathan Lacombe, et al.
Publicado: (2011)

How asthmatic patients use digital media looking for asthma information?
por: Neto, Herberto Jose Chong, et al.
Publicado: (2015)

The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
por: MacRae, Megan, et al.
Publicado: (2014)

Mechanisims of asthma and allergic disease – 1079. Evidence of platelet activation in asthmatic patients
por: Jin, Hyun Jung, et al.
Publicado: (2013)

Asthma diagnosis and treatment – 1015. Improvements in lung function in an indian population with IgE mediated asthma receiving omalizumab in a real-world setting
por: Guleria, Randeep, et al.
Publicado: (2013)

Use of Omalizumab to treat a nine-year old, with steroid-dependent, allergic asthma, adrenal insufficiency and vertebral compression fractures due to steroid induced severe osteoporosis
por: Ring, Alicia, et al.
Publicado: (2011)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2015)

Asthma diagnosis and treatment - 1027. Body mass index of asthmatic children in United Arab Emirates
por: Al-Hammadi, Suleiman, et al.
Publicado: (2013)

Asthma diagnosis and treatment – 1006. Perillae semen abolished allergic asthmatic response in murine model
por: Kim, Mi-Kyeong, et al.
Publicado: (2013)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
por: Hébert, Jacques, et al.
Publicado: (2012)

Measured depth of subcutaneous tissue on posterolateral arm of omalizumab patients
por: Potts, Ryan, et al.
Publicado: (2012)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Metabolomic applied to omalizumab effect in severe asthmatics – a preliminary result
por: Loureiro, Cláudia Chaves, et al.
Publicado: (2013)

Effective omalizumab treatment influenced eosinophil function in severe allergic asthmatics
por: Yan, Huacheng, et al.
Publicado: (2023)

Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)

Asthma diagnosis and treatment – 1013. Six month follow up on pediatric patients with severe persistent allergic asthma after on eyear of omalizumb therapy
por: Choudhuri, Tarun
Publicado: (2013)

282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study
por: Sztafińska, Anna, et al.
Publicado: (2017)

Pulmonary function and symptoms in asthmatics adolescents
por: Fontes, Vitor Joaquim Barreto, et al.
Publicado: (2015)

Transcriptional networks in whole blood of asthmatics
por: Kim, Young Woong, et al.
Publicado: (2014)

Asthma diagnosis and treatment – 1022. The differences of clinical profiles by house dust mite sensitzation in patients with asthmatics in Soonchunhyang University Hospital cohort
por: Jang, An-Soo, et al.
Publicado: (2013)

Omalizumab in Children with Severe Allergic Asthma: The Italian Real-Life Experience
por: Licari, Amelia, et al.
Publicado: (2017)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Severe asthma in childhood
por: de Benedictis, Fernando Maria
Publicado: (2015)

Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy
por: Velling, P, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nc8mfe3r9stdet0rji3b68pbev